VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026

Rhea-AI Summary

VSee (NASDAQ:VSEE) unveiled the VSee AI Robot at HIMSS 2026, a fully autonomous telehealth robot that navigates to patient bedsides without staff escort, using LiDAR and 30X optical/infrared night vision. Key capabilities include virtual rounding, telestroke response, programmable medication delivery, and integration via the no-code VSee AI Workflow Engine. The company cites platform scale: 1.5M video encounters/month and capacity for 1,800+ appointments/day, and promises customization timelines of 1 day to 1 month.

Positive

• Platform scale: 1.5M video encounters per month
• Operational capacity: 1,800+ appointments per day
• Rapid deployment: customization guaranteed in 1 day to 1 month
• Autonomous clinical use cases: virtual rounding, telestroke, med delivery

Negative

• No disclosed pricing, purchase orders, or commercial contract values
• No quantified customer adoption or revenue impact tied to the VSee AI Robot

News Market Reaction – VSEE

-6.14% 1.5x vol

7 alerts

-6.14% News Effect

+3.9% Peak Tracked

-15.0% Trough Tracked

-$899K Valuation Impact

$14M Market Cap

1.5x Rel. Volume

On the day this news was published, VSEE declined 6.14%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.9% during that session. Argus tracked a trough of -15.0% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $899K from the company's valuation, bringing the market cap to $14M at that time. Trading volume was above average at 1.5x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Current price: $0.285 52-week range: $0.2312–$2.52 Video encounters: 1.5 million per month +5 more

8 metrics

Current price $0.285 Prior to AI robot launch announcement

52-week range $0.2312–$2.52 52-week low and high levels

Video encounters 1.5 million per month Telehealth platform usage cited in release

Daily appointment capacity 1,800+ appointments per day Telehealth throughput capacity

Robot optical zoom 30X optical Bedside navigation and imaging capability

Clinical AI capabilities 100+ capabilities AI Workflow Engine design target

Customization timeline 1 day to 1 month Guaranteed timeline for common customizations

Providers onboarded 800+ providers LA County Department of Mental Health example

Market Reality Check

Price: $0.2890 Vol: Volume 444,884 is below t...

normal vol

$0.2890 Last Close

Volume Volume 444,884 is below the 20-day average of 597,053 (relative volume 0.75x). normal

Technical Shares at $0.285 are trading below the 200-day MA of $0.76 and 88.69% under the 52-week high.

Peers on Argus

Sector peers show mixed activity: BFRG appears in momentum scanners with a 5.67%...

2 Up

Sector peers show mixed activity: BFRG appears in momentum scanners with a 5.67% move up, while BEAT is up 11.15%. Two peers in the scanner are up, but sector momentum is flagged as stock-specific rather than a broad sector move.

Common Catalyst AI-related digital health activity appears in at least one peer headline (DRIO) but broad sector-wide AI news is limited.

Previous AI Reports

5 past events · Latest: Jan 12 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	AI platform launch	Positive	-5.9%	AI-driven Rural Health Transformation Solution targeting revenue recapture for hospitals.
Nov 20	Leadership & AI focus	Positive	+6.7%	Dr. Milton Chen named chairman to drive no-code, low-code AI infrastructure growth.
Jul 14	AI notes launch	Positive	+13.1%	AI Doctor Notes with 93% reduction in documentation time for Tele911 partnership.
Jul 14	Corrected AI notes PR	Positive	+13.1%	Correcting and replacing AI Doctor Notes release, reiterating 93% time reduction.
May 16	AI maternal project	Positive	+1.5%	Project MAMA AI-powered telehealth to reduce maternal deaths in rural Philippines.

Pattern Detected

AI-tagged announcements have generally led to positive 1-day moves, with one notable selloff on a major AI platform launch.

Recent Company History

Over recent AI-tagged releases, VSEE has focused on expanding its AI telehealth infrastructure: from Project MAMA for maternal care to AI Doctor Notes cutting documentation time by 93%, and an AI-driven Rural Health Transformation platform tied to a $10B/year CMS program. The current autonomous telehealth AI robot extends this strategy into hardware-enabled clinical workflows, building on prior no-code/low-code AI infrastructure messaging and large-scale telehealth deployments.

Historical Comparison

+5.7% avg move · In the past year, VSEE issued 5 AI-focused updates averaging 5.72% 1-day moves. The autonomous AI ro...

AI

+5.7%

Average Historical Move AI

In the past year, VSEE issued 5 AI-focused updates averaging 5.72% 1-day moves. The autonomous AI robot launch fits the pattern of AI-driven telehealth expansion.

AI initiatives progressed from maternal health and documentation automation to rural hospital transformation and now an autonomous telehealth robot integrated with the AI Workflow Engine.

Market Pulse Summary

The stock moved -6.1% in the session following this news. A negative reaction despite an AI-focused ...

Analysis

The stock moved -6.1% in the session following this news. A negative reaction despite an AI-focused product launch would fit a mixed historical pattern, where one major AI platform update saw a -5.86% move even as others were positive. The new autonomous telehealth robot builds on a platform already processing 1.5M video encounters per month, but the shares sit far below the $2.52 52-week high and under the 200-day MA, so concerns about commercialization speed, competitive pressure, or past financing overhangs could weigh on sentiment.

Key Terms

lidar, icu, telestroke, hipaa-compliant, +4 more

8 terms

lidar technical

"the VSee AI Robot uses advanced LiDAR navigation to independently travel hospital corridors"

Lidar, which stands for Light Detection and Ranging, is a technology that uses laser beams to create detailed, three-dimensional maps of the environment. It works like a sophisticated eye that measures distances by bouncing light off objects, helping machines see and understand their surroundings. For investors, lidar is important because it enables advancements in autonomous vehicles, robotics, and mapping, which can drive innovation and growth in related industries.

icu medical

"specialist coverage across emergency departments and ICUs at scale."

An ICU, or intensive care unit, is a hospital ward equipped and staffed to monitor and treat patients with life‑threatening illnesses or injuries that require constant attention and advanced medical support, like breathing machines or continuous medication. For investors, ICU capacity and related costs matter because high demand can signal increased use of hospital services, drive revenue for medical device and healthcare providers, strain a facility’s resources and margins, and influence regulatory and reimbursement pressures—similar to how a factory’s production line affects a manufacturer’s output and costs.

telestroke medical

"delivering true virtual rounding, rapid telestroke response, and specialist coverage"

Remote stroke care delivered by video and digital tools that lets a stroke specialist assess patients, review brain scans, and advise local clinicians in real time—like having an on-call expert join a hospital room by video. It matters to investors because telestroke can expand access to critical care without new buildings, alter hospital spending on staff and technology, drive demand for telehealth platforms and imaging equipment, and influence patient outcomes and reimbursement that affect healthcare revenue.

hipaa-compliant regulatory

"Secure patient identification - HIPAA-compliant, role-based access"

HIPAA-compliant means that a product, service, or organization follows the U.S. Health Insurance Portability and Accountability Act’s rules for protecting patients’ private health information, including technical controls, physical safeguards, and record-keeping. For investors, compliance matters because it reduces risks of costly fines, lawsuits and reputational damage, and it can be a requirement to sell into healthcare markets — like having a certified lockbox and an audit trail that reassures customers and regulators.

ai workflow engine technical

"integrating seamlessly into existing clinical AI ecosystems through VSee's proprietary AI Workflow Engine."

An AI workflow engine is software that coordinates and automates the steps needed to run artificial intelligence tasks — from gathering and preparing data, to running models, to routing results for review and deployment. Think of it as a conductor or factory line that keeps complex pieces moving in the right order automatically. Investors care because it helps companies scale AI work faster, lowers ongoing costs, reduces human error, and speeds product or decision improvements that can affect revenue and risk.

no-code/low-code technical

"a no-code/low-code AI activation layer that enables hospitals to deploy"

A no-code/low-code platform lets people build software, automations, or apps using visual tools like drag-and-drop blocks and simple settings instead of writing traditional computer code. For investors it matters because these platforms can speed product development, lower labor costs, and expand a company’s ability to adapt by enabling non‑technical staff to create solutions—potentially increasing productivity and reducing time-to-market risks.

ehr technical

"remote patient monitoring, and EHR integrations with fulfillment operations"

EHR stands for electronic health record, a digital version of a patient’s complete medical file that replaces paper charts and collects diagnoses, medications, test results and treatment history in one place. For investors, EHR systems matter because they drive recurring revenue for software and services, affect healthcare providers’ costs and efficiency, and create data assets and integration opportunities that can influence a company’s growth and regulatory risk.

triage medical

"Patient check-in & triage - reducing front-line staff burden at intake"

Triage is the process of sorting or prioritizing items based on their importance or urgency. In finance, it often involves evaluating investments, tasks, or issues to decide which ones need immediate attention and which can wait, helping individuals or organizations focus on what matters most. This approach ensures resources are used efficiently and critical matters are addressed promptly.

AI-generated analysis. Not financial advice.

Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort Required

LAS VEGAS, NV / ACCESS Newswire / March 10, 2026 / VSee (NASDAQ:VSEE), the leader in telehealth platform innovation, today announced the launch of the VSee AI Robot at HIMSS 2026 - the world's first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSee AI Robot enables remote clinicians to navigate directly to a patient's bedside without requiring onsite staff assistance, delivering true virtual rounding, rapid telestroke response, and specialist coverage across emergency departments and ICUs at scale.

The launch marks a pivotal inflection point in care delivery: For the first time, a single autonomous robot can replace or augment multiple manual workflows simultaneously - from remote physician rounding to medication and supplies delivery - while integrating seamlessly into existing clinical AI ecosystems through VSee's proprietary AI Workflow Engine.

"We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside," said Dr. Milton Chen, CEO of VSee. "This isn't a cart with a screen. This is an autonomous clinical teammate that multiplies what every provider on your team can do."

Autonomous Navigation Meets Clinical-Grade Intelligence

Unlike traditional telepresence carts that require staff to physically escort or reposition them, the VSee AI Robot uses advanced LiDAR navigation to independently travel hospital corridors, enter patient rooms, and position itself at the bedside - day or night, with 30X optical and infrared night vision. Its surgical-grade display delivers high-definition virtual encounters while programmable drawers enable secure medication and supply delivery on the same autonomous pass.

Key clinical capabilities include:

• Remote physician rounding & specialist consults - multisite coverage across ED, ICU, and med-surg

• Telestroke & rapid response - autonomous dispatch to bedside within minutes

• Patient check-in & triage - reducing front-line staff burden at intake

• Medication & supply delivery - programmable, secure, auditable

• Secure patient identification - HIPAA-compliant, role-based access

Powered by the VSee AI Workflow Engine: Designed for 100+ Clinical AI Capabilities, Zero IT Rebuild

The VSee AI Robot is powered by the VSee AI Workflow Engine, a no-code/low-code AI activation layer that enables hospitals to deploy and govern a library of clinical AI modules - from AI Copilot-assisted scheduling and coding to Early Warning vitals deterioration alerts and Stroke CT Hemorrhage notifications - without rebuilding existing IT infrastructure or enduring 12-month integration cycles.

The platform's modular Building Blocks architecture means health systems can configure and scale in days, not months - with VSee guaranteeing common customizations in as little as 1 day to 1 month.

Proven at scale, VSee's telehealth platform already powers over 1.5 million video encounters per month, and a capacity of 1,800+ appointments per day, and helped clients like LA County Department of Mental Health onboard 800+ providers in under 7 days.

Immediate Financial & Operational ROI

The VSee AI Robot is designed to deliver measurable ROI from day one:

• Optimize staff utilization - autonomous navigation eliminates the need for escort staff on virtual rounds

• Reduce staffing costs - one robot enables remote specialists to cover multiple facilities simultaneously

• Increase revenue - expand specialist service lines (telestroke, tele-ICU) without adding headcount

See It Live at HIMSS 2026

The VSee AI Robot will be on live demonstration at HIMSS 2026 in Las Vegas. Attendees can experience autonomous bedside navigation, live virtual rounding workflows, and the VSee AI Workflow Engine dashboard in person at two locations on the show floor:

• Live Robot Demo - VSee Booth #4468 | Watch the VSee AI Robot navigate and conduct a virtual patient encounter in real time

• VSee Platform Experience - VSee Booth #4468 | Deep-dive into the AI Workflow Engine, Building Blocks architecture, and integration ecosystem

Schedule a private meeting or demo at HIMSS: sales@vsee.com | vsee.com

About VSee Health

VSee is a leading telehealth platform company trusted by major health systems, federal agencies, and digital health innovators. Built on a no-code/low-code Building Blocks architecture, VSee's unified platform powers virtual care, clinical AI workflows, and now autonomous robotic telehealth delivery. VSee's Integration Ecosystem features rich data connectors and expert in-house integration teams, enabling a superior patient experience and efficient provider workflows - for the lowest lifecycle cost in the industry.

For more information, visit vsee.com or contact sales@vsee.com.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "plans," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-K and other SEC-filed documents. Such filing copies are available on the SEC's website www.sec.gov. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to rely on forward-looking statements.

Media Contact:
Anne Chang
VSee
media@vsee.com

Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health Inc.

View the original press release on ACCESS Newswire

FAQ

What is the VSee AI Robot announced at HIMSS 2026 (VSEE)?

The VSee AI Robot is a fully autonomous telehealth robot that navigates to patient bedsides without staff escort. According to VSee, it uses LiDAR, 30X optical/infrared night vision, and programmable drawers for secure medication and supply delivery in hospitals.

How does the VSee AI Robot integrate with hospital IT and clinical AI (VSEE)?

The robot integrates via the VSee AI Workflow Engine, a no-code/low-code AI activation layer for clinical modules. According to VSee, hospitals can deploy and govern 100+ AI capabilities without rebuilding existing IT infrastructure.

What clinical use cases does the VSee AI Robot support for hospitals (VSEE)?

The robot supports remote physician rounding, multisite specialist consults, telestroke rapid response, patient triage, and secure medication delivery. According to VSee, these features target ED, ICU, and med-surg workflows to reduce frontline staff burden.

What operational scale metrics did VSee disclose for its platform (VSEE)?

VSee reported its telehealth platform powers 1.5 million video encounters per month and a capacity of 1,800+ appointments per day. According to VSee, the platform also supported onboarding 800+ providers in under seven days for a client.

Will the VSee AI Robot deliver immediate financial ROI for hospitals (VSEE)?

VSee positions the robot to optimize staff utilization, reduce staffing costs, and increase revenue by expanding specialist services without adding headcount. According to VSee, these ROI claims are immediate but the release provides no disclosed pricing or contract-level revenue figures.